Regulation
Iowa Signs Law Doubling Medical Cannabis Dispensary Cap

Iowa’s medical cannabis patients have been navigating a program built around tight limits since it launched nearly a decade ago. One of those limits — a hard cap on how many dispensaries can hold a license — is now being doubled.
Gov. Kim Reynolds signed legislation on June 2, 2026 raising the state’s maximum dispensary count from five to ten. The measure passed with wide bipartisan support in both chambers and also allows out-of-state residents to enroll in Iowa’s program if they hold a certification from an Iowa-licensed healthcare provider — a notable expansion of eligibility.
For patients, particularly those in rural stretches of a state with few population centers and widely scattered healthcare facilities, the change addresses what the program’s own advisory board flagged years ago: five dispensaries statewide isn’t enough.
A Long-Requested Fix
The Iowa Medical Cannabidiol Board, which advises Iowa’s Department of Health and Human Services on the state’s medical cannabis program, put the problem plainly in a 2023 annual report. The board recommended the state be allowed to license additional dispensaries beyond the existing statutory ceiling, calling it necessary to give patients “greater geographical access” to medical cannabis products. All five available licenses had been operational since October 2021, and none had opened since — because the law wouldn’t permit it.
The dispensary map reflects a persistent mismatch. Iowa’s five locations are concentrated in a small number of communities, leaving patients in large areas of the state with long travel requirements. Every purchase requires an in-person visit to a licensed dispensary: registered patients must present their state-issued card and are subject to a purchase limit of no more than 4.5 grams of THC per 90-day period.
As MyCannabis covered when the bill cleared both chambers, the measure had strong legislative momentum before arriving on the governor’s desk. The June 2, 2026 signing converts that action into law.
Iowa HHS’s Bureau of Cannabis Regulation, which oversees licensing and compliance for manufacturers and dispensaries under the state’s medical cannabis framework, will manage the application and award process for the new licenses.
The Program’s Remaining Limits
Iowa’s medical cannabis framework operates under tighter constraints than most peer programs. The 4.5-gram-per-90-day purchase limit applies statewide, with two exceptions: practitioners can certify a higher amount for terminally ill patients, and established patients can request an increase from their original certifying provider.
Permitted product forms include oral preparations — capsules, tinctures, and sublingual products — along with topicals and vaporizable products. Cannabis flower for smoking remains prohibited under current state law. The law governing the program, enacted in 2017, established both the regulatory structure administered by Iowa HHS and the Medical Cannabidiol Board that advises on qualifying conditions, product forms, and dispensary siting.
The out-of-state registration provision is an incremental shift in a program that has historically required Iowa residency. Patients from other states who receive certification from an Iowa-licensed healthcare provider can now register — a practical consideration for border communities or patients who travel to Iowa for care. The provision doesn’t change what products are available; out-of-state registrants still need to visit a licensed Iowa dispensary in person to purchase.
Iowa’s Political Signal
The dispensary expansion drew near-unanimous legislative support — a notable data point in a state where cannabis legislation has otherwise advanced slowly. Iowa has no adult-use cannabis framework and no indication one is forthcoming. Reynolds vetoed psilocybin legislation in June 2025.
The dispensary cap increase had clear momentum from both sides of the aisle, framed consistently as a patient-access correction rather than a step toward broader liberalization. The Medical Cannabidiol Board’s documented recommendation gave the proposal institutional grounding that helped separate it from broader cannabis-policy debates.
What happens next is largely an administrative question. Iowa HHS will need to open an application period, review applicants against the Bureau of Cannabis Regulation’s licensing standards, and conduct inspections before any new dispensary can open. Patients in underserved areas of the state will see the benefit when new licenses clear the regulatory pipeline — not on the day the governor signed the bill.












